LONDON--(BUSINESS WIRE)--The biologic therapeutics market is expected to grow by USD 190.94 bn, progressing at a CAGR of almost 12% during the forecast period.
Click & Get Free Sample Report in Minutes
The strong R&D pipeline is one of the major factors propelling market growth. However, factors such as issues related to entry of new biologics will hamper the market growth.
More details: https://www.technavio.com/report/biologic-therapeutics-market-industry-analysis
Biologic Therapeutics Market: Product Landscape
Based on the product, the antibody therapeutics segment is expected to witness lucrative growth during the forecast period.
Biologic Therapeutics Market: Geographic Landscape
By geography, North America is going to have a lucrative growth during the forecast period. About 56% of the market’s overall growth is expected to originate from North America. The US is a key market for biologic therapeutics in North America.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Related Reports on Health Care Include:
-
Capsule Endoscopes Market by Product and Geography - Forecast and Analysis 2020-2024- The capsule endoscopes market size has the potential to grow by USD 160.35 million during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 7.95%. To get extensive research insights: Click and get FREE sample report in minutes
- China In-Vitro Diagnostics Market by End-user and Application - Forecast and Analysis 2020-2024- The China in-vitro diagnostics market size has the potential to grow by USD 6.93 billion during 2020-2024, and the market’s growth momentum will decelerate at a CAGR of 16.61%. To get extensive research insights: Click and get FREE sample report in minutes
Companies Covered:
- AbbVie Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
What our reports offer:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers market data for 2019, 2020, until 2024
- Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Antibody therapeutics - Market size and forecast 2019-2024
- Vaccines - Market size and forecast 2019-2024
- Cell therapy - Market size and forecast 2019-2024
- Gene therapy - Market size and forecast 2019-2024
- Other therapies - Market size and forecast 2019-2024
- Market opportunity by Product
Market segmentation by application
- Oncology
- Autoimmune and inflammatory diseases
- Hematology
- Other applications
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
